Limerick BioPharma Raises $15 Million
Limerick BioPharma Inc., a South San Francisco-based developer of solutions for improving drug efficacy, has raised $15 million in Series C funding. OVP Venture Partners led the round, and was joined by return backers ARCH Venture Partners, Sevin Rosen Funds and Altitude Funds.
15 July 2009•2 mins read
